Dual PPARα/γ Agonist Tesaglitazar Reduces Atherosclerosis in Insulin-Resistant and Hypercholesterolemic ApoE*3Leiden Mice-Reference-Cited by-同舟云学术

Dual PPARα/γ Agonist Tesaglitazar Reduces Atherosclerosis in Insulin-Resistant and Hypercholesterolemic ApoE*3Leiden Mice

Published:2006-11 Issue:11 Volume:26 Page:2560-2566
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Zadelaar A. Susanne M.¹,Boesten Lianne S.M.¹,Jukema J. Wouter¹,van Vlijmen Bart J.M.¹,Kooistra Teake¹,Emeis Jef J.¹,Lundholm Erik¹,Camejo German¹,Havekes Louis M.¹

Affiliation:

1. From the Department of Cardiology (A.S.M.Z., J.W.J., L.M.H.), Leiden University Medical Center; TNO-Gaubius Laboratory (A.S.M.Z., L.S.M.B., T.K., J.J.E., L.M.H.), Biomedical Research Unit; Department of General Internal Medicine (L.S.M.B., L.M.H.), Leiden University Medical Center; Hemostasis and Thrombosis Research Center (B.J.M.vV.), Leiden University Medical Center, Leiden, The Netherlands; AstraZeneca (E.L., G.C.), Mölndal, Sweden.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference45 articles.

1. Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia

2. Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol

3. Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis

4. Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes

5. The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time-restricted feeding attenuates hypercholesterolaemia and atherosclerosis development during circadian disturbance in APOE∗3-Leiden.CETP mice;eBioMedicine;2023-07

2. Time to run: Late rather than early exercise training in mice remodels the gut microbiome and reduces atherosclerosis development;The FASEB Journal;2022-12-23

3. Time to run: Late rather than early exercise training in mice remodels the gut microbiome and reduces atherosclerosis development;2022-11-29

4. Aging attenuates diurnal lipid uptake by brown adipose tissue;Aging;2022-10-04

5. The Role of Peroxisome Proliferator-Activated Receptor Gamma and Atherosclerosis: Post-translational Modification and Selective Modulators;Frontiers in Physiology;2022-03-02